Cardiol Therapeutics Inc.
CRDL
Positions held
Your positionsCRDL isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $157.97M | Enterprise value | $125.90M | Trailing P/E | — | Forward P/E | -5.67 |
| PEG | — | Price / book | 8.95 | Beta | 0.73 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -1.9% | ROA | -90.9% | Debt / equity | 0.00 |
| Current ratio | 5.55 | Free cash flow | -$15.48M | Analyst recommendation | strong_buy | Mean target | $8.38 |
| 52w high | $2.34 | 52w low | $0.88 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$6.1M | -$10.8M | -$7.2M | -$10.0M | -$8.4M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.9M | -$9.7M | -$8.0M | -$10.2M | -$7.7M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$33.8M | -$36.7M | -$28.1M | -$30.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$34.3M | -$40.3M | -$29.8M | -$41.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-16 · Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
2026-09-16 · Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds
2026-09-14 · 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-10 · Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?
2026-08-25 · Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?
2026-08-24 · Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?
2026-08-12 · Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
Price (daily)
Full chart · RSI · MACD · patterns